Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 2 | 7 | 2024 | 12143 | 0.700 |
Why?
|
Metformin | 2 | 2024 | 906 | 0.680 |
Why?
|
Proteome | 4 | 2022 | 1862 | 0.630 |
Why?
|
Cytosine | 1 | 2019 | 211 | 0.620 |
Why?
|
Metabolome | 4 | 2023 | 987 | 0.590 |
Why?
|
Metabolomics | 7 | 2023 | 1657 | 0.490 |
Why?
|
Hypoglycemic Agents | 3 | 2024 | 3081 | 0.490 |
Why?
|
Blood Glucose | 3 | 2024 | 6391 | 0.400 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5840 | 0.290 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2021 | 851 | 0.250 |
Why?
|
Proteomics | 3 | 2023 | 3845 | 0.240 |
Why?
|
Genomics | 1 | 2020 | 5820 | 0.230 |
Why?
|
Oleic Acids | 1 | 2023 | 74 | 0.210 |
Why?
|
Chemokine CX3CL1 | 1 | 2021 | 63 | 0.190 |
Why?
|
Genome-Wide Association Study | 4 | 2024 | 12688 | 0.180 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2023 | 269 | 0.170 |
Why?
|
Hypercalcemia | 1 | 2022 | 423 | 0.170 |
Why?
|
Carnitine | 1 | 2019 | 252 | 0.150 |
Why?
|
Anti-Obesity Agents | 1 | 2021 | 227 | 0.150 |
Why?
|
End Stage Liver Disease | 1 | 2022 | 352 | 0.150 |
Why?
|
Specimen Handling | 1 | 2022 | 702 | 0.140 |
Why?
|
Eating | 1 | 2024 | 1538 | 0.140 |
Why?
|
Amino Acids | 1 | 2023 | 1718 | 0.140 |
Why?
|
Coronary Disease | 2 | 2022 | 5919 | 0.140 |
Why?
|
Insulin Resistance | 2 | 2021 | 3963 | 0.140 |
Why?
|
Prediabetic State | 1 | 2021 | 549 | 0.130 |
Why?
|
Fatty Liver | 1 | 2021 | 789 | 0.120 |
Why?
|
Models, Genetic | 1 | 2024 | 3446 | 0.110 |
Why?
|
Liver Diseases | 1 | 2022 | 1297 | 0.110 |
Why?
|
Cardiovascular Diseases | 4 | 2023 | 15498 | 0.110 |
Why?
|
Obesity | 4 | 2023 | 12938 | 0.110 |
Why?
|
Body Weight | 1 | 2024 | 4618 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2019 | 1250 | 0.100 |
Why?
|
Phenylalanine | 2 | 2024 | 366 | 0.100 |
Why?
|
Humans | 25 | 2024 | 761423 | 0.090 |
Why?
|
Overweight | 1 | 2021 | 2413 | 0.090 |
Why?
|
Incidence | 4 | 2022 | 21341 | 0.090 |
Why?
|
Body Mass Index | 3 | 2022 | 12951 | 0.080 |
Why?
|
Heart Diseases | 1 | 2022 | 2785 | 0.080 |
Why?
|
Risk Factors | 5 | 2023 | 74167 | 0.080 |
Why?
|
Homeostasis | 1 | 2019 | 3321 | 0.080 |
Why?
|
Echocardiography | 1 | 2021 | 4991 | 0.080 |
Why?
|
Zebrafish | 1 | 2019 | 3007 | 0.080 |
Why?
|
Life Style | 1 | 2019 | 3914 | 0.070 |
Why?
|
Glucose | 1 | 2019 | 4347 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2024 | 4811 | 0.070 |
Why?
|
Heart Failure | 2 | 2021 | 11674 | 0.070 |
Why?
|
Nerve Degeneration | 1 | 2009 | 748 | 0.060 |
Why?
|
Male | 11 | 2024 | 360736 | 0.060 |
Why?
|
Female | 11 | 2024 | 392581 | 0.060 |
Why?
|
alpha-Synuclein | 1 | 2009 | 750 | 0.050 |
Why?
|
Aptamers, Peptide | 1 | 2022 | 28 | 0.050 |
Why?
|
Diet | 1 | 2021 | 8074 | 0.050 |
Why?
|
Adult | 9 | 2024 | 221148 | 0.050 |
Why?
|
Middle Aged | 9 | 2024 | 220826 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2022 | 6395 | 0.050 |
Why?
|
Dipeptides | 1 | 2024 | 391 | 0.050 |
Why?
|
Leucine | 1 | 2023 | 548 | 0.050 |
Why?
|
Aged | 7 | 2024 | 169235 | 0.050 |
Why?
|
Homoarginine | 1 | 2021 | 9 | 0.050 |
Why?
|
Orotic Acid | 1 | 2021 | 24 | 0.050 |
Why?
|
Fish Products | 1 | 2021 | 30 | 0.050 |
Why?
|
Mississippi | 1 | 2021 | 95 | 0.050 |
Why?
|
Longitudinal Studies | 3 | 2022 | 14599 | 0.050 |
Why?
|
Calcitonin | 1 | 2022 | 329 | 0.050 |
Why?
|
Spermine | 1 | 2021 | 70 | 0.050 |
Why?
|
Meat Products | 1 | 2021 | 96 | 0.050 |
Why?
|
Uridine | 1 | 2021 | 141 | 0.040 |
Why?
|
Polyamines | 1 | 2021 | 133 | 0.040 |
Why?
|
Animals | 6 | 2024 | 168441 | 0.040 |
Why?
|
Cystatin C | 1 | 2021 | 269 | 0.040 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2019 | 82 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 13637 | 0.040 |
Why?
|
Blood Proteins | 1 | 2024 | 1180 | 0.040 |
Why?
|
Proline | 1 | 2021 | 457 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2022 | 675 | 0.040 |
Why?
|
Waist Circumference | 1 | 2022 | 934 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2024 | 2927 | 0.040 |
Why?
|
Diet, Reducing | 1 | 2021 | 485 | 0.040 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2021 | 416 | 0.040 |
Why?
|
Diphosphonates | 1 | 2022 | 636 | 0.040 |
Why?
|
Sodium | 1 | 2022 | 1588 | 0.030 |
Why?
|
Cysteine | 1 | 2021 | 892 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2022 | 12456 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2116 | 0.030 |
Why?
|
Child | 1 | 2024 | 80162 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2022 | 1188 | 0.030 |
Why?
|
Adolescent | 1 | 2024 | 88313 | 0.030 |
Why?
|
Parkinson Disease | 1 | 2009 | 2877 | 0.030 |
Why?
|
Vegetables | 1 | 2021 | 1196 | 0.030 |
Why?
|
Phenotype | 2 | 2024 | 16606 | 0.030 |
Why?
|
Fatty Acids | 1 | 2023 | 1808 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2421 | 0.030 |
Why?
|
Signal Transduction | 3 | 2023 | 23441 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2022 | 22168 | 0.030 |
Why?
|
Mice | 4 | 2024 | 81509 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22164 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2021 | 1723 | 0.030 |
Why?
|
Collagen | 1 | 2021 | 2638 | 0.030 |
Why?
|
Gene Deletion | 1 | 2019 | 2667 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2021 | 2133 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2455 | 0.020 |
Why?
|
Computer Simulation | 1 | 2024 | 6238 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2321 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2022 | 39117 | 0.020 |
Why?
|
Weight Loss | 1 | 2021 | 2683 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8529 | 0.020 |
Why?
|
Health Behavior | 1 | 2021 | 2641 | 0.020 |
Why?
|
Calcium | 1 | 2022 | 5727 | 0.020 |
Why?
|
Heart | 1 | 2022 | 4405 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9612 | 0.020 |
Why?
|
Pyrimidines | 1 | 2021 | 3027 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 41446 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2021 | 5115 | 0.020 |
Why?
|
Inclusion Bodies | 1 | 2009 | 281 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 2009 | 405 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12330 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10548 | 0.020 |
Why?
|
Stroke Volume | 1 | 2021 | 5497 | 0.020 |
Why?
|
Insulin | 1 | 2019 | 6602 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15838 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20093 | 0.010 |
Why?
|
Microtubules | 1 | 2009 | 1074 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2023 | 15941 | 0.010 |
Why?
|
United States | 2 | 2022 | 72339 | 0.010 |
Why?
|
Algorithms | 1 | 2024 | 14026 | 0.010 |
Why?
|
Brain | 1 | 2009 | 27107 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22163 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29620 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26112 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9535 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 64651 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2009 | 14409 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 80582 | 0.010 |
Why?
|
Disease Progression | 1 | 2009 | 13502 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 11902 | 0.010 |
Why?
|
Neurons | 1 | 2009 | 9462 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2009 | 17912 | 0.000 |
Why?
|
Mutation | 1 | 2009 | 30045 | 0.000 |
Why?
|
Concepts
(139)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(44)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_